_version_ 1784797898082353152
author Girgis, Suzette
Lin, Shun Xin Wang
Pillarisetti, Kodandaram
Banerjee, Arnob
Stephenson, Tara
Ma, Xuewen
Shetty, Shoba
Yang, Tong-Yuan
Hilder, Brandi W.
Jiao, Qun
Hanna, Brett
Adams, Homer C.
Sun, Yu-Nien
Sharma, Amarnath
Smit, Jennifer
Infante, Jeffrey R.
Goldberg, Jenna D.
Elsayed, Yusri
author_facet Girgis, Suzette
Lin, Shun Xin Wang
Pillarisetti, Kodandaram
Banerjee, Arnob
Stephenson, Tara
Ma, Xuewen
Shetty, Shoba
Yang, Tong-Yuan
Hilder, Brandi W.
Jiao, Qun
Hanna, Brett
Adams, Homer C.
Sun, Yu-Nien
Sharma, Amarnath
Smit, Jennifer
Infante, Jeffrey R.
Goldberg, Jenna D.
Elsayed, Yusri
author_sort Girgis, Suzette
collection PubMed
description
format Online
Article
Text
id pubmed-9512742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-95127422022-09-28 Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma Girgis, Suzette Lin, Shun Xin Wang Pillarisetti, Kodandaram Banerjee, Arnob Stephenson, Tara Ma, Xuewen Shetty, Shoba Yang, Tong-Yuan Hilder, Brandi W. Jiao, Qun Hanna, Brett Adams, Homer C. Sun, Yu-Nien Sharma, Amarnath Smit, Jennifer Infante, Jeffrey R. Goldberg, Jenna D. Elsayed, Yusri Target Oncol Correction Springer International Publishing 2022-08-01 2022 /pmc/articles/PMC9512742/ /pubmed/35913648 http://dx.doi.org/10.1007/s11523-022-00904-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Girgis, Suzette
Lin, Shun Xin Wang
Pillarisetti, Kodandaram
Banerjee, Arnob
Stephenson, Tara
Ma, Xuewen
Shetty, Shoba
Yang, Tong-Yuan
Hilder, Brandi W.
Jiao, Qun
Hanna, Brett
Adams, Homer C.
Sun, Yu-Nien
Sharma, Amarnath
Smit, Jennifer
Infante, Jeffrey R.
Goldberg, Jenna D.
Elsayed, Yusri
Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title_full Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title_fullStr Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title_full_unstemmed Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title_short Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
title_sort correction: translational modeling predicts efficacious therapeutic dosing range of teclistamab for multiple myeloma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512742/
https://www.ncbi.nlm.nih.gov/pubmed/35913648
http://dx.doi.org/10.1007/s11523-022-00904-y
work_keys_str_mv AT girgissuzette correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT linshunxinwang correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT pillarisettikodandaram correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT banerjeearnob correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT stephensontara correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT maxuewen correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT shettyshoba correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT yangtongyuan correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT hilderbrandiw correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT jiaoqun correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT hannabrett correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT adamshomerc correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT sunyunien correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT sharmaamarnath correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT smitjennifer correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT infantejeffreyr correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT goldbergjennad correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma
AT elsayedyusri correctiontranslationalmodelingpredictsefficacioustherapeuticdosingrangeofteclistamabformultiplemyeloma